Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews

2020·Animal Study -

Positive

Effect of combined doses of Δ 9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats

2020·Animal Study -

Positive

Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats

2017·Animal Study -

Positive

The Use of Release-Active Antibody-Based Preparations for Vertigo Prevention in Adults

2015·Review/Other

Positive

Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system

2014·Animal Study -

Positive

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.

2013·Animal Study -

Positive

Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

2013·Animal Study -

Positive

Motion Sickness, Stress And The Endocannabinoid System.

2010·Review/Other

Positive

The Effects of Cannabidiol and Tetrahydrocannabinol on Motion‐Induced Emesis in Suncus murinus.

2008·Review/Other

Positive

Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret

2007·Review/Other

Positive

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

2003·Meta-analysis